NxStage Launches Nurse Hero Campaign to Recognize Home Hemodialysis Nurses Patients, nurses and nephrologists nominate their "Nurse Hero" in celebration of Nephrology Nurses Week
LAWRENCE, Mass., Aug. 25, 2014 /PRNewswire/ -- NxStage® Medical, Inc., a leading manufacturer of innovative dialysis products, today launched the Nurse Hero Campaign a first-of-its-kind home hemodialysis nurse recognition that honors the dedication and compassion of the nephrology nursing community. Beginning today, patients, nephrologists and fellow nurses can nominate their "Nurse Hero," a home hemodialysis nurse who has exhibited exceptional devotion and passion to their dialysis patients' well-being and happiness. Nominations can be submitted online at www.Nxstage.com/hero to be featured for voting during Nephrology Nurses Week. The nurse with the most votes will be announced mid-October with a video on the NxStage website.
"I've been in the home program for 8 years and they have been my most gratifying years as a nurse," said Melanie Porter, RN, who has been a dialysis nurse for over 20 years. "Thanks to NxStage and the System One™, I feel patients' gratitude every day. This heartwarming and humbling campaign gives us, as home hemodialysis nurses, the rare opportunity to be recognized by the people we so deeply care about, as well as a chance to show people how passionate we are about making a difference in people's quality of life."
Patients, nurses, and physicians may nominate their "Nurse Heroes" by visiting www.Nxstage.com/hero between August 25 and September 8. Voting will occur from September 9 to September 19, and the winner will be announced on October 14. Nominations are open to all home hemodialysis nurses.
Following the training nurses provide on the System One, patients often report an increased sense of freedom and flexibility when they can perform their own care at home. The Nurse Hero campaign allows patients to express sentiments of appreciation for the extraordinary care these "Nurse Heroes" provide to countless, and sometimes fearful, patients on a daily basis.
"Simply put, there is no more pivotal role than the home training nurse in making life-changing home hemodialysis therapy and its tremendous benefits available to patients" said Joe Turk, president of NxStage Medical, Inc. "The Nurse Hero campaign allows patients and healthcare professionals to recognize this, showing their appreciation and respect for each nurse's personal investment in patient well-being."
To learn more about NxStage's Nurse Hero Contest or about NxStage Medical, Inc., visit www.nxstage.com. Join the conversation on Facebook at facebook.com/NxStage, Twitter at @NxStage and YouTube at youtube.com/user/NxStage.
Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs - at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical NxStage Medical, Inc.
NxStage is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq.
VP, Investor Relations
SOURCE NxStage Medical, Inc.